Bml-210
Product Sizes
5 mg
£296.00
SIH-348-5MG
25 mg
£1004.00
SIH-348-25MG
About this Product
- SKU:
- SIH-348
- Additional Names:
- N1-(2-aminophenyl)-N8-phenyloctanediamide
- CAS Number:
- 537034-17-6
- CE/IVD:
- Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
- Extra Details:
- Bml-210 is a novel non-hydroxamic acid histone deacetylase (HDAC) inhibitor that has shown promising activity in epigenetic modulation. Although its primary research applications have been in oncology, particularly in inducing growth inhibition, apoptosis, and differentiation in leukemia cell lines, its mechanism of action is increasingly relevant to neuroscience. HDAC inhibitors are being explored for their neuroprotective effects, especially in the context of neurodegenerative diseases such as Alzheimer's and Huntington's disease. By modulating chromatin structure and gene expression, Bml-210 may influence neuronal plasticity, memory formation, and neuroinflammation. Its non-hydroxamic acid structure offers a unique pharmacological profile, potentially reducing off-target effects and improving therapeutic specificity. As interest in epigenetic therapies for neurological disorders grows, Bml-210 represents a valuable tool for probing the role of HDACs in the central nervous system.
- Molecular Weight:
- 339.4
- Purity:
- >98%
- Shipping Conditions:
- Ambient
- Source:
- Synthetic
- Storage Conditions:
- -20[o]C
- Supplier:
- StressMarq Biosciences
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Inhibitors
- Manufacturer's Data Sheet:https://www.stressmarq.com/products/small-molecules/inhibitor/bml-210-sih-348/
